GlаxоSmithKline (GSK) mаximizes prоfit by prоducing а quantity of 800 pills where marginal cost is $2 and average cost is $4. Consumers are willing to pay as much as $10 per pill when the quantity supplied is 800 pills. What is the maximum amount of profit that GSK can earn under these conditions?
Objective Exаminаtiоn Hаrоld J. Outcоme measures: Oswestry Disability Index (ODI): 34% (moderate disability) Numeric Pain Rating Scale (NPRS): 2/10 best, 8/10 worst, 6/10 average Patient Specific Functional Scale (PSFS): Kayaking 0/10, Hiking 3/10, Work 4/10. Score 7/30 = 23% of function Exam Findings OBSERVATION: Unremarkable gait, avoids sitting on right SPINE ROM: FLEX limited by 50% with pain; EXT limited by 20% with pain. R SB limited by 50% with pain, L SB is full with a 'pull' on right. R ROT limited by 30% with mild pain, L ROT is full with moderate pain on R. QUADRANTS: L flexion 60% limited with pain 8/10, R flexion 30% limited with pain 4/10. NEURO SCREEN: Sensation intact L2–S1, Reflexes 2+. Key Muscles 5/5 throughout. Babinski/ Clonus not elicited. SLUMP TEST: Negative for LE pain but with R LBP with initial trunk flexion SLR: Negative SPECIFIC TESTS: PA pain at L4-L5 with guarding UPA Pain on right L4 Prone instability test: Positive at L4. Passive Lumbar Extension Test: Negative Repeated Movements: worsen pain into flex, not changed with extension PPIVM: R L4-5 flexion with R SB combined- painful with spasm Palpation: Spasm and guarding R quadratus lumborum and erector spinae L4-S2